The PARADIGM International Liaison Group (PILG) is a co-creation hub acting as an operational platform to connect PARADIGM with like-minded initiatives.
These include key Innovative Medicine Initiatives and other international efforts focused on the co-development and implementation of patient engagement practices in medicines development.
The PILG supports the members of the PARADIGM consortium to create a well-defined roadmap addressing the strategic and operational needs and resources for patient engagement, focusing on the three phases targeted by PARADIGM:
Early dialogues with
regulators and HTA bodies
The PILG is instrumental, agile and aligned with PARADIGM’s scope in the following ways:
provides advice to PARADIGM in developing relationships
establishes an international vision of patient engagement
reduces fragmentation and duplication
relevante of PARADIGM strategic objectives